Personalis, Inc. announced the appointment of Lonnie Shoff to the Personalis Board of Directors effective August 2, 2022; Ms. Shoff brings extensive clinical diagnostics experience including executive roles at Thermo Fisher and Roche Diagnostics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -0.76% | -9.72% | -38.10% |
08/05 | Transcript : Personalis, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (PSNL) PERSONALIS Reports Q1 Revenue $19.5M, vs. Street Est of $18.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.10% | 6.8Cr | |
+43.36% | 5.81TCr | |
-5.31% | 4.05TCr | |
+37.52% | 3.9TCr | |
+14.75% | 2.67TCr | |
-12.56% | 2.66TCr | |
-22.45% | 1.9TCr | |
+0.04% | 1.22TCr | |
+25.12% | 1.2TCr | |
+26.04% | 1.19TCr |
- Stock Market
- Equities
- PSNL Stock
- News Personalis, Inc.
- Personalis, Inc. Appoints Lonnie Shoff to Its Board of Directors